Latest in News & Research

Fecal Microbiota Profile Differs for Melanoma, Healthy Controls

Differences also seen for microbiomes in those with early- and late-stage melanoma, including higher alpha diversity in early-stage

By Dermsquared Editorial Team | | September 06, 2023

Alterations in Infant Gut Microbiota Precede Development of Eczema

Similar patterns also observed in C-section-born infants

By Lori Solomon (HealthDay News) | | September 05, 2023

Psychosocial Impact of Vitiligo

Navigating the emotional and social challenges and enhancing support strategies for patients with vitiligo

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen, MD, MBA, MPH [1,2] | | September 05, 2023

Atopic Dermatitis Increases Risk for Inflammatory Bowel Disease

Risk varies by age, atopic dermatitis severity, and inflammatory bowel disease subtype

By Lori Solomon (HealthDay News) | | August 31, 2023

Important Update

Winter Clinical Hawaii in ON for Maui!

By Dermsquared Senior Clinical Advisors | | August 30, 2023

Has There Been a Change in Spironolactone Prescribing for Acne?

Oral antibiotics and spironolactone prescribed at about the same frequency in 2020 compared with more antibiotics in 2017

By Dermsquared Editorial Team | | August 23, 2023

Is NRS30 Valid for Assessing Treatment Effect for Hidradenitis Suppurativa Pain?

Achievement of NRS30 at week 16 associated with moderate-to-large improvements in clinical, patient-reported outcome measures

By Dermsquared Editorial Team | | August 23, 2023

Clascoterone Cream Safe, Efficacious for Moderate-to-Severe Acne

Long-term safety and efficacy favorable during treatment in patients aged 12 years and older with moderate-to-severe acne

By Dermsquared Editorial Team | | August 22, 2023

Long-Term Benefit Seen for Upadacitinib in Moderate-to-Severe AD

Patients switching from dupilumab to upadacitinib had additional incremental improvement in clinical response

By Dermsquared Editorial Team | | August 22, 2023

Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis

12 weeks of treatment also yields benefits in peak pruritus, change in SCORing Atopic Dermatitis

By Elana Gotkine (HealthDay News) | | August 22, 2023

Percentage of Women Mohs Fellows, Program Directors Has Increased

Significant positive trend seen between percentage of female representation and year since 1996

By Elana Gotkine (HealthDay News) | | August 18, 2023

Co-Occurrence of Psoriasis and Rheumatic Diseases Common

Psoriasis significantly linked to psoriatic arthritis, osteoarthritis, gout, fibromyalgia, RA, ankylosing spondylitis, Sjogren syndrome, systemic sclerosis

By Elana Gotkine (HealthDay News) | | August 18, 2023

Update on Pathogenesis of Vitiligo

Analyzing vitiligo’s complex pathways and exploring the convergence theory

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen, MD, MBA, MPH [1,2] | | August 15, 2023

Important Update

Winter Clinical Hawaii and Maui Wildfires

By Dermsquared Senior Clinical Advisors | | August 14, 2023

Model Predicts New Psoriatic Arthritis in People With Psoriasis

Model relies on readily available clinical variables

By Lori Solomon (HealthDay News) | | August 11, 2023

Is Uptitration of Baricitinib to 4 mg Beneficial for Severe Alopecia Areata?

25.9 percent of patients without response to baricitinib 2 mg achieved SALT score of 20 or lower after 24 weeks of 4 mg baricitinib

By Dermsquared Editorial Team | | August 10, 2023

Is Risankizumab Safe, Efficacious for Plaque Psoriasis in the Long Term?

Long-term treatment for up to five years was well tolerated and had high efficacy

By Dermsquared Editorial Team | | August 09, 2023

Reinforced Learning Model Can Improve Sensitivity of Skin Cancer Diagnosis

Correct diagnoses made by dermatologists increased with reinforcement learning, incorporating human preferences into AI model

By Elana Gotkine (HealthDay News) | | August 09, 2023

Higher Risk for Schizophrenia Seen Among Patients With Eczema

Authors say awareness of this association can aid collaborative patient care

By Lori Solomon (HealthDay News) | | August 08, 2023

Do Curettage and Cryosurgery Provide Clearance for Basal Cell Carcinomas?

Curettage and cryosurgery provide excellent clinical clearance rates with one and two free-thaw cycles in nonfacial basal cell carcinomas

By Dermsquared Editorial Team | | August 02, 2023

Do Clinical Symptoms Improve With Dupilumab in Bullous Pemphigoid?

Rapid and sustained improvement in clinical indicators and laboratory examination results seen after treatment

By Dermsquared Editorial Team | | August 02, 2023

Highlighting and Reviewing Recent Publications on Vitiligo

Navigate the latest insights in vitiligo with a comprehensive update on prevalence, pathogenesis, and treatments.

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen, MD, MBA, MPH [1,2] | | August 02, 2023

Illuminating the Path to Skin Repigmentation

Phototherapy for the Treatment of Vitiligo – What Every Dermatologist Should Know

By Charles Dunn, MD [1], Rajiv Nathoo, MD,1 Monique Kumar, MD [1] | | July 31, 2023

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026